Results 11 to 20 of about 13,009 (197)

Monocarboxylate transporter and lactate metabolism

open access: yesJournal of Physical Fitness and Sports Medicine, 2012
For many years, lactate was considered as a metabolic waste product, and a cause of fatigue during exercise. However, lactate is now known as a carbohydrate fuel source, shuttled between cells and tissues.
Yu Kitaoka, Daisuke Hoshino, Hideo Hatta
doaj   +3 more sources

Cooperative transport mechanism of human monocarboxylate transporter 2 [PDF]

open access: yesNature Communications, 2020
Proton-linked monocarboxylate transporters (MCTs) facilitate monocarboxylate efflux in glycolytically active cells and regulate transport down in glycolytically inactive cells.
Bo Zhang   +14 more
doaj   +3 more sources

Monocarboxylate Transporter 8 Deficiency: From Pathophysiological Understanding to Therapy Development

open access: yesFrontiers in Endocrinology, 2021
Genetic defects in the thyroid hormone transporter monocarboxylate transporter 8 (MCT8) result in MCT8 deficiency. This disorder is characterized by a combination of severe intellectual and motor disability, caused by decreased cerebral thyroid hormone ...
Ferdy S. van Geest   +3 more
doaj   +2 more sources

Monocarboxylate transporters in the brain and in cancer [PDF]

open access: yesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016
Monocarboxylate transporters (MCTs) constitute a family of 14 members among which MCT1-4 facilitate the passive transport of monocarboxylates such as lactate, pyruvate and ketone bodies together with protons across cell membranes. Their anchorage and activity at the plasma membrane requires interaction with chaperon protein such as basigin/CD147 and ...
Pérez-Escuredo J   +6 more
openaire   +4 more sources

Monocarboxylate transporters in cancer

open access: yesMolecular Metabolism, 2020
Tumors are highly plastic metabolic entities composed of cancer and host cells that can adopt different metabolic phenotypes. For energy production, cancer cells may use 4 main fuels that are shuttled in 5 different metabolic pathways. Glucose fuels glycolysis that can be coupled to the tricarboxylic acid (TCA) cycle and oxidative phosphorylation ...
Valéry L. Payen   +4 more
openaire   +3 more sources

Rare cause of ketolysis: Monocarboxylate transporter 1 deficiency

open access: yesThe Turkish Journal of Pediatrics, 2022
Background. Monocarboxylate transporter 1 (MCT1) deficiency (MIM #616095) is a relatively new identified cause of recurrent ketoacidosis triggered by fasting or infections. MCT1 was first described in 2014 by van Hasselt et al. to result from both
Ayşe Ergül Bozacı   +1 more
doaj   +1 more source

Monocarboxylate transporter expression in mouse brain [PDF]

open access: yesAmerican Journal of Physiology-Endocrinology and Metabolism, 1998
Although glucose is the major metabolic fuel needed for normal brain function, monocarboxylic acids, i.e., lactate, pyruvate, and ketone bodies, can also be utilized by the brain as alternative energy substrates. In most mammalian cells, these substrates are transported either into or out of the cell by a family of monocarboxylate transporters (MCTs),
E M, Koehler-Stec   +4 more
openaire   +2 more sources

Monocarboxylate Transporter 1 Deficiency and Ketone Utilization [PDF]

open access: yesNew England Journal of Medicine, 2014
Ketoacidosis is a potentially lethal condition caused by the imbalance between hepatic production and extrahepatic utilization of ketone bodies. We performed exome sequencing in a patient with recurrent, severe ketoacidosis and identified a homozygous frameshift mutation in the gene encoding monocarboxylate transporter 1 (SLC16A1, also called MCT1 ...
Hasselt, P.M. van   +22 more
openaire   +11 more sources

Monocarboxylate Transporter 8 Deficiency: Delayed or Permanent Hypomyelination?

open access: yesFrontiers in Endocrinology, 2020
Monocarboxylate transporter 8 (MCT8) deficiency or the Allan-Herndon-Dudley Syndrome (AHDS) is an X-linked psychomotor disability syndrome with around 320 clinical cases described worldwide.
Pieter Vancamp   +2 more
doaj   +1 more source

Uptake and Advanced Therapy of Butyrate in Inflammatory Bowel Disease

open access: yesImmuno, 2022
The pathogenesis and refractory nature of inflammatory bowel disease (IBD) are related to multiple factors, including genetic factors, environmental factors, and abnormalities in gut microbial diversity, which lead to decreased levels of short-chain ...
Shinji Ota, Hirotake Sakuraba
doaj   +1 more source

Home - About - Disclaimer - Privacy